
[Cancer Research 57, 5243-5245, December 1, 1997]
© 1997 American Association for Cancer Research
NADH Dehydrogenase Deficiency in an Apoptosis-resistant Mutant Isolated from a Human HL-60 Leukemia Cell Line
Akihiro Kataoka,
Masaru Kubota1,
Ken-ichiro Watanabe,
Machiko Sawada,
Seiji Koishi,
Ying Wei Lin,
Ikuya Usami,
Yuichi Akiyama,
Toshiyuki Kitoh and
Kenshi Furusho
Department of Pediatrics, Faculty of Medicine, Kyoto University, Kawahara-cho 54, Shogoin, Sakyo-ku, Kyoto 606, Japan
An apoptosis-resistant mutant (VC-33) was selected from HL-60 by alternating exposure to camptothecin and etoposide. VC-33 cells demonstrated resistance to apoptosis as induced not only by camptothecin and etoposide but by a variety of other agents as well, including 1-ß-D-arabinofuranosylcytosine, hydroxyurea, calcium ionophore (A23187), cycloheximide, and UV irradiation. In an effort to identify the mechanism of such apoptosis resistance, a mRNA differential display analysis was used. Among a total of 12 bands with reduced expression in VC-33 cells, 1 cDNA clone was isolated that was hybridized to the wild-type transcript but not to the VC-33 transcript on Northern blotting. Partial sequence of this gene revealed 98% homology to mitochondrial NADH dehydrogenase subunit 5. When cell growth and intracellular ATP levels under glucose starvation were measured, VC-33 cells were found to be more sensitive than wild-type cells. Thus, NADH dehydrogenase deficiency may contribute, at least in part, to the mechanism of resistance to apoptosis in VC-33 cells.
1 To whom requests for reprints should be addressed. Phone: 81-75-751-3295; Fax: 81-75-752-2361.
Received 9/10/97.
Accepted 10/16/97.
This article has been cited by other articles:

|
 |

|
 |
 
D. Chandra, J.-W. Liu, and D. G. Tang
Early Mitochondrial Activation and Cytochrome c Up-regulation during Apoptosis
J. Biol. Chem.,
December 20, 2002;
277(52):
50842 - 50854.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Joshi, L. Li, B. G. Taffe, Z. Zhu, S. Wahl, H. Tian, E. Ben-Josef, J. D. Taylor, A. T. Porter, and D. G. Tang
Apoptosis Induction by a Novel Anti-Prostate Cancer Compound, BMD188 (a Fatty Acid-containing Hydroxamic Acid), Requires the Mitochondrial Respiratory Chain
Cancer Res.,
September 1, 1999;
59(17):
4343 - 4355.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Association for Cancer Research.